Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia

被引:0
|
作者
Connor Walsh
Anthony Hunter
Terra Lasho
Christy Finke
Rhett Ketterling
Rami Komrokji
Ayalew Tefferi
Abhishek Mangaonkar
Matthew Howard
Naseema Gangat
Aref Al-Kali
Najla Al Ali
Eric Padron
Mrinal M. Patnaik
机构
[1] Mayo Clinic,Alix School of Medicine
[2] Moffitt Cancer Center,Division of Hematology and Oncology
[3] Mayo Clinic,Division of Hematology, Department of Internal Medicine
[4] Mayo Clinic,Department of Laboratory Medicine and Pathology
[5] Moffitt Cancer Center,Deparmenent of Malignant Hematology
来源
Leukemia | 2022年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1693 / 1696
页数:3
相关论文
共 50 条
  • [1] Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia
    Walsh, Connor
    Hunter, Anthony
    Lasho, Terra
    Finke, Christy
    Ketterling, Rhett
    Komrokji, Rami
    Tefferi, Ayalew
    Mangaonkar, Abhishek
    Howard, Matthew
    Gangat, Naseema
    Al-Kali, Aref
    Ali, Najla Al
    Padron, Eric
    Patnaik, Mrinal M.
    LEUKEMIA, 2022, 36 (06) : 1693 - 1696
  • [2] Differential Prognostic Impact of IDH1 and IDH2 Mutations in Chronic Myelomonocytic Leukemia
    Walsh, Connor M.
    Hunter, Anthony
    Lasho, Terra
    Finke, Christy
    Komrokji, Rami S.
    Shah, Mithun V.
    Tefferi, Ayalew
    Mangaonkar, Abhishek A.
    Howard, Matthew T.
    Gangat, Naseema
    Al-Kali, Aref
    Al Ali, Najla
    Padron, Eric
    Patnaik, Mrinal M.
    BLOOD, 2021, 138 : 3684 - +
  • [3] IDH1 and IDH2 mutations in pediatric acute leukemia
    A K Andersson
    D W Miller
    J A Lynch
    A S Lemoff
    Z Cai
    S B Pounds
    I Radtke
    B Yan
    J D Schuetz
    J E Rubnitz
    R C Ribeiro
    S C Raimondi
    J Zhang
    C G Mullighan
    S A Shurtleff
    B A Schulman
    J R Downing
    Leukemia, 2011, 25 : 1570 - 1577
  • [4] IDH1 and IDH2 mutations in pediatric acute leukemia
    Andersson, A. K.
    Miller, D. W.
    Lynch, J. A.
    Lemoff, A. S.
    Cai, Z.
    Pounds, S. B.
    Radtke, I.
    Yan, B.
    Schuetz, J. D.
    Rubnitz, J. E.
    Ribeiro, R. C.
    Raimondi, S. C.
    Zhang, J.
    Mullighan, C. G.
    Shurtleff, S. A.
    Schulman, B. A.
    Downing, J. R.
    LEUKEMIA, 2011, 25 (10) : 1570 - 1577
  • [5] IDH1 and IDH2 Mutations in Chondrosarcomas
    Nafa, K.
    Agaram, N. P.
    Borsu, L.
    Schwartz, G.
    Healey, J.
    Ladanyi, M.
    Hameed, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 700 - 700
  • [6] IDH1 and IDH2 Mutations in Gliomas
    Adam L. Cohen
    Sheri L. Holmen
    Howard Colman
    Current Neurology and Neuroscience Reports, 2013, 13
  • [7] IDH1 and IDH2 Mutations in Gliomas
    Ducray, Francois
    Marie, Yannick
    Sanson, Marc
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (21): : 2248 - 2249
  • [8] Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
    Ragon, Brittany Knick
    DiNardo, Courtney D.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (06) : 537 - 546
  • [9] IDH1 and IDH2 Mutations in Gliomas
    Cohen, Adam L.
    Holmen, Sheri L.
    Colman, Howard
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (05)
  • [10] IDH1 and IDH2 Mutations in Gliomas
    Yan, Hai
    Parsons, D. Williams
    Jin, Genglin
    McLendon, Roger
    Rasheed, B. Ahmed
    Yuan, Weishi
    Kos, Ivan
    Batinic-Haberle, Ines
    Jones, Sian
    Riggins, Gregory J.
    Friedman, Henry
    Friedman, Allan
    Reardon, David
    Herndon, James
    Kinzler, Kenneth W.
    Velculescu, Victor E.
    Vogelstein, Bert
    Bigner, Darell D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (08): : 765 - 773